Literature DB >> 31061198

Epistaxis and gross haematuria with severe thrombocytopaenia associated with influenza vaccination.

Abdullah Almohammadi1,2, Michael S Lundin2,3, Calvin Abro2,3, Borys Hrinczenko1,2.   

Abstract

Epistaxis may be attributed to many causes during the winter including dry mucous membranes from low indoor humidity from heating. However, epistaxis may also be due to thrombocytopaenia. Immune thrombocytopaenia purpura (ITP) is an autoimmune disorder causing thrombocytopaenia. Viral infections sometimes lead to ITP. Vaccines, predominantly the measles-mumps-rubella vaccine, have been associated with the development of ITP. There are several published case reports regarding influenza vaccine induced ITP. However, an association between ITP and influenza vaccination has not been firmly proven yet. We report the case of an adult with three episodes of epistaxis, each within 1 week of receiving a yearly influenza trivalent inactivated vaccine, the last episode being more severe and also featuring gross haematuria. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  general practice/family medicine; haematology (incl blood transfusion); immunological products and vaccines; influenza; public health

Mesh:

Substances:

Year:  2019        PMID: 31061198      PMCID: PMC6510128          DOI: 10.1136/bcr-2019-229423

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

Review 1.  Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines.

Authors:  M Rinaldi; C Perricone; O-D Ortega-Hernandez; R Perricone; Y Shoenfeld
Journal:  Lupus       Date:  2014-05       Impact factor: 2.911

2.  A case-control study to assess the risk of immune thrombocytopenia associated with vaccines.

Authors:  Lamiae Grimaldi-Bensouda; Marc Michel; Elodie Aubrun; Pamela Leighton; Jean-Francois Viallard; Daniel Adoue; Nadine Magy-Bertrand; Guillaume Tisserand; Mehdi Khellaf; Jean-Marc Durand; Philippe Quittet; Olivier Fain; Bernard Bonnotte; Anne Sophie Morin; Nicolas Limal; Nathalie Costedoat-Chalumeau; Nathalie Morel; Brigitte Pan-Petesch; Olivier Decaux; Matthieu Mahevas; Michel Ruel; Karim Sacre; Francois Lefrere; Lucien Abenhaim; Bertrand Godeau
Journal:  Blood       Date:  2012-10-24       Impact factor: 22.113

3.  Vaccination-Associated relapse of immune thrombocytopenia.

Authors:  J G Kelton
Journal:  JAMA       Date:  1981 Jan 23-30       Impact factor: 56.272

4.  Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.

Authors:  Jacob A Udell; Rami Zawi; Deepak L Bhatt; Maryam Keshtkar-Jahromi; Fiona Gaughran; Arintaya Phrommintikul; Andrzej Ciszewski; Hossein Vakili; Elaine B Hoffman; Michael E Farkouh; Christopher P Cannon
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

5.  Thrombocytopenia after immunization of Canadian children, 1992 to 2001.

Authors:  Taj Jadavji; David Scheifele; Scott Halperin
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

6.  Recurrent Immune Thrombocytopenia After Influenza Vaccination: A Case Report.

Authors:  Uri Hamiel; Iris Kventsel; Ilan Youngster
Journal:  Pediatrics       Date:  2016-11-08       Impact factor: 7.124

Review 7.  Immune thrombocytopenic purpura: the treatment paradigm.

Authors:  Roberto Stasi
Journal:  Eur J Haematol Suppl       Date:  2009-03

8.  Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients.

Authors:  Joji Nagasaki; Masahiro Manabe; Kentaro Ido; Hiroyoshi Ichihara; Yasutaka Aoyama; Tadanobu Ohta; Yoshio Furukawa; Atsuko Mugitani
Journal:  Case Rep Hematol       Date:  2016-02-21
  8 in total
  1 in total

1.  Risk Factors and Psychological Analysis of Chronic Immune Thrombocytopenia in Children.

Authors:  Ying Sun; Sili Long; Wenjun Liu
Journal:  Int J Gen Med       Date:  2020-12-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.